WSAVA CE is one of the most important benefits we provide to our members but, to ensure that we provide appropriate content, we need to ensure that it fits the regulation models of as many of our member associations’ countries as possible. To help us, please complete the short questionnaire below to help us understand the regulatory situation in your country. We will take all the responses we receive into account in planning WSAVA CE going forward.
Complete the questionnaire here
The WSAVA Executive Board (EB) is composed of volunteer veterinarians, who are responsible for the oversight and strategy of the WSAVA. Currently, there is an opening on the EB for another 'Board Member'. This position has a 2-year term and will start after the WSAVA World Congress 2019 in Toronto, Canada. Find more information here:
Assembly Member Info
“Ready access by healthcare professionals to pharmaceuticals (e.g., medicines, anesthetics/analgesics, etc), biologicals (e.g., vaccines, etc), parasiticides, and antiseptics is one of the key pillars of appropriate patient care, whether in human or veterinary medicine. Inequities in availability and access exist between various regions of the world for a variety of reasons. We call upon key stakeholders (regulatory authorities, manufacturers, and healthcare professionals) to seek solutions that would broaden access while maintaining the sanctity of the veterinary-client-patient+/- pharmacist relationship, where warranted.”
This joint position statement stems from an earlier more comprehensive WSAVA statement (in the Resources section) which was developed based on member engagement on this issue.
We’re delighted that the following WSAVA members have already endorsed our Position Statement:
Past poll results